TP53 and ovarian carcinoma: To assess the effect of stromal SPHK1 expression on ovarian cancer growth and metastasis in vivo, a syngeneic mouse ovarian cancer cell line, MOSE-HRas (p53-null HRas-MOSE, Agadjanian et al. in preparation) was utilized.